This website has been developed by Besins Healthcare (UK) Ltd.

This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Testogel® (testosterone) within the UK.

Please confirm that:

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

Managing patients

Managing Patients

Printable materials for patients

Download the Testogel® 16.2 mg/g gel Patient Package Leaflet.

Download the Testogel® 40.5 mg, transdermal gel in sachet Patient Package Leaflet.

PATIENT APP

Support patient self-management with the T Track app

Encourage your patients to review their symptoms using the Ageing Males’ Symptom (AMS) scale in the T Track app and monitor their progress over time.

T Track app available for both iOS and Android phones.

Support patient self-management with the T Track app

REQUEST MORE INFORMATION ON TESTOGEL® 16.2 MG/G GEL

    Please fill in the form below to join our consent list where you’ll receive the latest healthcare, medical and promotional information around BHUK products via email and/or SMS. This includes medical and scientific information and events, invitations to Besins-organised promotional speaker meetings, promotional information and material and links to available online resources.

    Therapy areas of interest:
    *Required field

    By filling in this form and clicking the “Submit” button, I confirm I am a healthcare professional in the UK or Ireland and I consent to receiving healthcare, medical and scientific related information, by email or other electronic means. This may include promotional information on products promoted by Besins Healthcare. If you’d like more information, you can read our privacy notice here.

    Adverse events should not be submitted via this form.

    TES/2022/048. February 2023.

    Adverse event reporting

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: pharmacovigilance@besins-healthcare.com